All Announcements
Angus Miln, Ali Ramadan & Helen Pantelides Joins Cooley
Cooley has further expanded its emerging companies and venture capital (ECVC) practice in London with the addition of three new partners: Angus Miln, Ali Ramadan and Helen Pantelides. The trio reinforces Cooley’s position as the preeminent leader in high-growth, disruptive industries for private companies and investors in the UK, Europe and globally.
Read MoreWilliam Pao Joins Cooley LLP in Los Angeles as Partner
William K. Pao joins Cooley’s Los Angeles office as a partner in the firm’s securities litigation + enforcement group and global litigation department. He arrives from O’Melveny & Myers where he served as chair of the fintech group and co-chair of the artificial intelligence (AI) group. At Cooley, Pao will advise a broad range of clients – including cryptocurrency and block chain pioneers – on securities, regulatory and litigation issues.
Read MoreClaire Keast-Butler & James Maton Join Cooley as Partners in London
Cooley has appointed Claire Keast-Butler and James Maton as the new partners in charge of the firm’s London office.
Read MoreCooley Enhances Tech and Venture Capital Capabilities in Miami
Cooley has launched an official presence in Miami’s rapidly developing technology and venture capital hub with the opening of the firm’s 19th global office.
Read MoreKelly Batts Named New Chief Diversity Officer at Cooley
He joins from Deloitte, where he was a managing director focused on diversity, equity and inclusion (DEI) strategy and workforce transformation across a range of industries.
Read MoreRachel Proffitt to Succeed Joe Conroy as Cooley’s Next CEO
Cooley announced that Rachel Proffitt has been selected as the firm’s next chief executive officer, effective January 1, 2024. She will succeed Joe Conroy who has held the position since January 1, 2008. Conroy will continue in his role as chairman.
Read MoreCooley Secures Win for Sequenom Board in Securities Class Action
Cooley represented the former board of directors of Sequenom, a molecular diagnostics company, in a nearly seven-year-long securities class action brought by former investors in the company. Lawyers Koji Fukumura, Peter Adams, Sarah Lightdale, Barrett Anderson and Dylan Scott led the Cooley team advising the board.
Read More